Day: October 12, 2016

Dolutegravir (Tivicay), an anti-retroviral drug for HIV, has just been approved for funding by Pharmac. In this case, it means that the drug will be fully-funded in public hospitals and the community, so long as specialist-approval is given. Tivicay is an integrase strand transfer inhibitor (INSTI), which basically means that it stops HIV from replicating (and […]

If you’re aged between 13 and 19 and feeling the creativity bug bite, then enter InsideOUT’s multimedia art competition. There are three categories for you to unleash your ideas on: film, writing and art. You can even enter all categories, and multiple times (though InsideOUT would prefer if you entered a maximum of three times […]